Testosterone treatment for hypogonadal men with organ-confined prostate cancer and unequivocal hypogonadism is under scrutiny for its potential association with cancer recurrence. Physicians are cautious due to the testosterone dependence of metastatic prostate cancer. Previous studies lacked...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.